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Abstract 
Introduction: To improve current public health strategies in suicide prevention and mental health, governments, 
researchers and private companies increasingly use information and communication technologies, and more 
specifically Artificial Intelligence and Big Data. These technologies are promising but raise ethical challenges rarely 
covered by current legal systems. It is essential to better identify, and prevent potential ethical risks. Objectives: The 
Canada Protocol - MHSP is a tool to guide and support professionals, users, and researchers using AI in mental 
health and suicide prevention. Methods: A checklist was constructed based upon ten international reports on AI and 
ethics and two guides on mental health and new technologies. 329 recommendations were identified, of which 43 
were considered as applicable to Mental Health and AI. The checklist was validated, using a two round Delphi 
Consultation. Results: 16 experts participated in the first round of the Delphi Consultation and 8 participated in the 
second round. Of the original 43 items, 38 were retained. They concern five categories: "Description of the 
Autonomous Intelligent System" (n=8), "Privacy and Transparency" (n=8), "Security" (n=6), "Health-Related 
Risks" (n=8), "Biases" (n=8). The checklist was considered relevant by most users, and could need versions tailored 
to each category of target users. 
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Table 1 : The Canada Protocol – the ethical checklist 
 
DESCRIPTION   
Objectives Describe your project's objectives and/or rationale and describe the role and functioning of your Autonomous Intelligent System 
Technology 
Name and describe the technologies and techniques used (e.g. supervised or unsupervised learning, 
machine learning, random forest, decision tree...). You can refer to the report of the AI Initiative incubated 
at Harvard http://ai-initiative.org/wp-content/uploads/2017/08/Making-the-AI-Revolution-work-for-
everyone.-Report-to-OECD.-MARCH-2017.pdf. Mention the names of any technological intermediary or 
supplier allowing you to use the technology (e.g. technical provider, cloud provider)  
Funding & 
conflict of interest 
Indicate all sources of funding for your project (public and private) and who might have an interest (e.g. 
financial, political) in your Autonomous Intelligent System 
Credentials 
If you have noted that you or someone in your team has an expertise in relation to the Autonomous 
Intelligent System (e.g. in a document, a webpage, an interview), clearly indicate the name of the 
professional, their technical, academic or medical credentials, and their training (e.g. "Professor Smith, 
PhD in computer systems engineering from Harvard University. Specialist in the Online Detection of 
Depression") 
Target population Describe your target population and its size, or identify its subgroups and their sizes. Describe if and how the target population (and, or its subgroups) assisted in the design of your Autonomous Intelligent System. 
Evidence 
If you made claims about your Autonomous Intelligent System's efficacy, performance, or benefits, please 
justify them and provide the evidence underlying them. If you have mentioned or used scientific papers, 
please cite your sources 
Testing If you have run your Autonomous Intelligent System under adversarial examples or worst-case scenarios, describe the type of tests used and their outcomes 
Complaints Describe the process whereby users can formally complain or express their concerns about your Autonomous Intelligent System   
PRIVACY & TRANSPARENCY   
Responsibility Describe who will be legally accountable for your Autonomous Intelligent System's actions or decisions 
Data collection 
Describe what data have been collected and used (for the training, evaluation and operational phases), 
where they are stored, who collected the data, who will have access to the data, and what safeguards are in 
place to ensure secure storage 
Accessibility In all the documents or texts, confirm that you have used a language adapted to target users and, when relevant, accommodated special needs some users may have. 
Informed consent 
State whether you have obtained informed consent and, if so, how, when, and from whom. Describe its 
nature (formal, implied, renewable, dynamic) and include the exact wording on the consent form. Note 
whether you have received ethical approval from an institution (eg: hospital, university) for your consent 
forms 
Consent withdrawal 
State whether you have specified the duration of the consent and whether you have implemented consent 
withdrawal mechanisms (e.g. opt-out clause, unsubscribe option). Specify what happens if an user wants to 
stop using the AIS or delete his or her information 
Access to the data Access to the data: State if an individual can access any data related to him or her and obtain the data in a clear and structured export document. If this is not possible, explain why 
Right to be forgotten Describe whether an individual can retrieve and erase all of his or her information, and if so, how. Describe the mechanism 
Minors 
Note whether information concerning minors is used for the Autonomous Intelligent System. If it is, and it 
is intentionally collected, please indicate whether parental consent is required. If it is, and it is 
unintentionally collected, please describe what can be done to remove this information   
SECURITY   
Embedded recording 
mechanism 
If you have used a technology to monitor and record all your Autonomous Intelligent System's decisions 
and actions, detail how and in what circumstances these records could be made available to authorities, 
external observers or auditors  
Third-parties Indicate who has access to the data (individuals and organizations), and whether identifying information about participants is included in accessible data 
Data protection Detail all the measures taken to protect any sensitive and personal information 
Audit trails Explain who has access to the data and when 
Autonomy Explain if your system has the autonomy to take actions or make decisions on its own. If yes, detail the degree of autonomy of your Autonomous Intelligent System (e.g. partial or complete)  
Moderation 
Explain if your Autonomous Intelligent System requires human intervention or moderation. If yes, 
describe who will have access to your Autonomous Intelligent System, and what will the guides regulating 
their intervention be   
HEALTH-RELATED RISKS   
Type of care 
Is your Autonomous Intelligent System helping its owners to provide the target population with the 
optimal treatment or treatment as usual? Indicate the criteria (and their sources) for optimal treatment or 
treatment as usual 
Crisis & contigency 
planning 
List the criteria for evaluating the risk exposure of your Autonomous Intelligent System. Describe your 
plan in case of emergency, disaster, or suicidal crisis (the intervention protocol). If possible, specify what 
type of behaviors and environments are considered as being at risk and explain the rationale in a simple 
way 
Non-maleficience Explain whether your Autonomous Intelligent System could harm, incommode, or embarass a user and, if so, how. Explain how you avoid or minimize this risk 
Misuse Describe potential misuses of your Autonomous Intelligent System (e.g. describe a possible negative scenario to indicate what could potentially happen to a user) and describe your mitigation strategies 
Emotions detection If your Autonomous Intelligent System detects user's emotions, state how, and for what purpose. Explain whether the user is informed and if so, how 
Emotions control If your Autonomous Intelligent System can provoke emotions, describe how users are informed of this possibility, the emotions that may be provoked, their intensity, and possible impact on users 
Relationship  
Is the user aware that he or she is interacting with a machine? Describe whether your Autonomous 
Intelligent System can create a relationship with users, and if so, how. Describe how the relationship might 
affect a user 
Public awareness Describe the impact on users and potential users of public dissemination of information about your Autonomous Intelligent System and the process of its development   
BIASES   
Ethics If you have requested an expertise on ethics during the design of your Autonomous Intelligent System, detail the parties involved and their contributions 
Exclusion & 
discrimination 
Explain if there are risks of exclusion or discrimination related to your Autonomous Intelligent System 
(e.g. based on gender, race, age, religion, politics, health, sexual orientation, etc.) 
Stigmatization Describe how you avoided using languages, images, and other content that could stigmatize users (e.g., reference to guidelines on safe media reporting and public messaging about suicide and and mental illness) 
Detection 
If applicable, explain any potential detection errors that might be made by your Autonomous Intelligent 
System (e.g. false positives, false negatives) and estimate their extent (e.g. precision, recall). Describe any 
potential adverse consequences for users. If applicable, describe any incidental finding made by your 
Autonomous Intelligent System 
Data handling If applicable, describe the nature and purpose of any data manipulation (e.g. cleaning, transformation) and by whom they were performed. Describe what will be done with the metadata 
Data selection Describe where the data came from, how you accessed them (e.g. through an API) and if you think there might be a selection or sampling bias (e.g. the data comes from an API or a spectrum bias) 
Data transformation 
If applicable, describe the nature and purpose of any statistical transformations applied to your data. 
Describe any potential bias or risk related to the data transformation (e.g. ecological fallacy, confounding 
factors)  
Other 
If you have identified other potential methodological or scientific biases, describe them and their potential 
ethical consequences (e.g.1. an excessively long consent form could affect the informed consent; e.g.2. the 
presence of a floor effect in the measurements could constrain an Autonomous Intelligent System’s ability 
to detect a behavior) 
 
  
Introduction 
Mental health care is deeply transformed by Information and Communication Technologies (ICT) 
and in particular Artificial Intelligence. It brings new exciting promises, from better diagnosing 
clients (Masri & Jani, 2012), to improving clinical decision making (Bennett & Doub, 2016; 
Bennett & Hauser, 2013). 
This has become a major field of interest for multiple countries. For example, the Canadian 
government has recently promoted the concept of E-Mental Health (Mahajan et al., 2014). It is 
defined as a way to help “people living with mental health problem or illness feel to more 
knowledgeable and better express their needs” (Mahajan et al., 2014; MHCC, 2017). One specific 
domain benefits from this technological trend: suicide prevention (MHCC, 2018). 
Mental Health and Suicide are indeed two interlinked themes. A 2014 World Health Organization 
Report considers suicide prevention to be the priority condition which is the focus of their Global 
Strategy for Mental Health (WHO, 2017). It also identifies several objectives: improving the way 
suicide rates are monitored, suicidal individuals are detected, and psychological help is delivered 
(Varathan & Talib, 2014; WHO, 2014). In order to meet these ambitious goals, governments (e.g. 
Canada), researchers and private companies (e.g. Facebook) are increasingly using Artificial 
Intelligence (Luxton, 2015; Mörch et al., 2018).  
The term “Artificial Intelligence” designates a very wide field of study, which may elicit both 
ethical concerns and hopes for more effectively prevention suicides and treating mental health 
problems (CNIL, 2017). It is defined as the domain interested in the study and design of intelligent 
machines (McCarthy, 1998). Its goal is to “build machines that are capable of performing tasks 
that we define as requiring intelligence, such as reasoning, learning, planning, problem-solving, 
and perception” (Luxton, 2015, p. 15). The term has become popular, but is difficult to accurately 
define. A recent international report suggested it may be better to use the term: Autonomous 
Intelligent System (AIS) (IEEE, 2017). In the context of mental health care, some researchers have 
used the term, Intelligence Care Providers (ICP) (Luxton, 2015). There are also many types of AI 
varying in methods and terminology. The most widespread type of AI is its sub-branch: Machine 
Learning (Demiaux & Si Abdallah, 2017). 
 
Generally speaking, the whole field is commonly associated with “Big Data” (BD). This term is 
defined as the constant increase of generated data and the development of techniques to analyze 
them (Kitchin, 2014). These two domains are often associated and raise numerous ethical 
questions. Many studies, books, and reports have been published on ethical issues concerning AI 
(Brundage et al., 2018; Demiaux & Si Abdallah, 2017; IEEE, 2017). It is important to note that 
almost all these ethical dilemmas are new and go beyond the scope of the present legal systems 
(Villani et al., 2017). 
 
Suicide prevention is no exception: the use of AI poses many new ethical, technical, and scientific 
challenges. There is however a paradox. Recently published studies that use BD or AI in suicide 
prevention rarely mention encountering ethical issues or challenges (Mörch et al., 2018). This 
relative absence of ethics in such a scrutinized field appears surprising. Firstly, there is an 
identified challenge: current guidelines and ethics codes do not always cover the ethical issues that 
are pertinent to health care and Artificial Intelligence. Secondly, today computer engineers and 
experts from around the world now talk of the concept of “moral overload” (IEEE, 2017). This 
expression means that AI developers and users frequently feel overwhelmed by the magnitude of 
the ethical risks, and do not feel competent, nor trained to address those risks. 
 
This article proposes a simple tool for people who want to use AI in mental health and suicide 
prevention: a checklist to identify and anticipate ethical issues, called the Canada Protocol - 
MHSP. This is the first validated instrument of its kind in AI Ethics. This tool, created by the 
authors, was designed to cover the challenges identified in the field of suicide prevention and 
mental health, in ethics and AI and ICT in health care. This paper presents the protocol and its 
validation process by an international committee of 16 professionals and experts, using a two-
round Delphi Consultation. 
 
The purpose of the creation of this checklist is to contribute to ethical education and to the 
improvement of practices when AI and BD are used in mental health care and suicide prevention. 
This checklist was constructed for use by AI developers, researchers, and decision makers willing 
to use AI in suicide prevention, and professionals and practitioners considering using AI. 
 Methodology 
a. Checklist 
The Canada Protocol - MHSP is a checklist. Checklists have long been used in mental health care, 
to elaborate list of potential symptoms in order to orient treatment (e.g. the Symptom 90 Checklist 
Revised (Derogatis, 1979; Derogatis & Unger, 2010)), or to better detect specific disorders (e.g. 
the Post-Traumatic Disorder Checklist) (Weathers, Litz, Herman, Huska, & Keane, 1993). 
Checklists are generally used to help clinicians, but they can also be used to help researchers assess 
the quality of studies (e.g. the National Institute for Clinical Excellence’s checklist - NiCe) 
(Excellence, 2009). An important example is the Preferred Reporting Items for Systematic Reviews 
(PRISMA), which was designed by the RAND Foundation to improve the quality of systematic 
reviews (Moher, Liberati, Tetzlaff, & Altman, 2009). The PRISMA checklist is comprised of 27 
items and a flow diagram. The original intent of the creators was to increase awareness of what 
constitutes a scientifically sound review. This approach favors guidance over sanctioning. The 
Canada Protocol was inspired by this type of approach. The authors tailored a checklist to their 
field of study, AI in mental health care and suicide prevention.  
 
b. Design of the checklist 
The authors did not identify an appropriate theoretical framework as guidance during the 
elaboration of the checklist. However, in order to scientifically reinforce and strengthen this 
study’s approach, the European Society of Human Reproduction and Embryology’s (ESHRE) best 
practices in the design of medical guidelines was used for inspiration (Vermeulen, 2018): 1. 
Choose a topic, 2. Create a group to develop the guidelines, 3. Scope the guidelines, 4. Formulate 
Key Questions, 5. Find evidence, 6. Evidence Synthesis, 7. Recommendation development, 8. 
Writing the guideline draft, 9. Stakeholder Consultation, 10. Approval, 11. Publication, 
Dissemination and Implementation. 
In developing our checklist, we followed most of the cited steps. Some were excluded because the 
Delphi consultation already corresponded to steps 9 and 10 and as previously mentioned, this study 
does not create guidelines, but a checklist built on guiding ethical principles.  
 
After having chosen the topic (step 1), the development group composed of two researchers was 
created: one specialized in psychology and new technologies (Carl-Maria Mörch, lead author) and 
one specialized in ethics and AI (Abhishek Gupta). They met on a regular basis (step 2), twice a 
month for six months. The initial work consisted of gathering existing recommendations from 
international reports on AI and ethics (n=10), important articles on this topic, and declarations in 
ethics in mental health and new technologies (n=3). It was determined that developing new 
recommendations on this topic would be less pertinent than regrouping and selecting existing 
recommendations and guidelines formulated by experts. This approach addresses a current 
problem in psychology: too many guidelines exist and it has become unclear which ones to trust 
or favour (Drife, 2010). By following and promoting existing recommendations, the authors hoped 
to increase the relevance of their work. The team read and extracted each mention of ethical issues 
in all documents concerning Artificial Intelligence. Overall, 450 potential ethical challenges, 
biases and risks were identified. After eliminating duplicate items, all the non-pertinent or 
redundant items were filtered. The items that were too specific, unclear, or not based on an ethical 
consideration (e.g. too technical) were considered non-pertinent. The remaining 329 items were 
divided into 9 categories: Fairness and Biases, Introductory Questions, Methodological Issues, 
Social Relevance and Validity, Transparency & Explainability, Controllability & Security, 
Autonomy, Responsibility. Of these 329 items, the lead researcher excluded all the articles that 
were not on Artificial Intelligence, were not applicable to the field of suicide prevention and mental 
health, were too technical for mental health professionals, or recommendations that were only 
applicable to the military (e.g. drones). 285 items were excluded and only 44 were retained. A 
scientific supervisor specializing in new technologies and ethics in suicide prevention (Brian 
Mishara) revised the checklist, its formulation and categorization. The first version of the checklist 
was comprised of 5 categories: “Description of the Autonomous Intelligent System” (n=12), 
“Privacy and Transparency” (n=8), “Security” (n=6), “Health-Related Risks” (n=9), “Biases” 
(n=9). 
 c. Theoretical context 
The Canada Protocol Checklist’s approach has two main theoretical frameworks: First, its goal is 
to facilitate responsible and civic education on new technologies, as expressed in the “Civic 
Media” movement from MIT’s Media Lab (Zuckerman, 2014). It is interested in the use of new 
technologies to promote social change and enhance civic participation, including in health care.  
Secondly, this study uses critical studies on BD and AI (Boyd & Crawford, 2012; Ménard, 
Mondoux, Ouellet, & Bonenfant, 2016) to consider technological innovations from a scientific and 
epistemological point of view. One of its objectives is to analyze the use of technologies rather 
than the discourse concerning them. For instance, the discourse concerning BD and AI often 
considers them to be promising and revolutionary, but their practice can also be criticized for its 
lack of awareness on potential biases and ethical challenges (Bowker, 2014). 
 
d. The Delphi Methodology 
In order to reinforce the internal validity of the checklist, the authors used the Delphi consultation 
method, developed in the 1950’s by the RAND (Research and Development) Foundation 
(Letrilliart & Vanmeerbeek, 2011) and since used regularly in health care. It is an iterative method 
that consists of 2-or-more rounds of consultation with experts on a specific topic or tool. Typically, 
the expert panel has to study content submitted by a research team, and then give their opinion 
anonymously. In each round, the experts see the aggregated results, and sometimes a recall of his 
or her own responses. The procedure stops when a consensus has been reached (2011). A panel 
has been considered to require a minimum of 15 participants (Hasson, Keeney, & McKenna, 
2000).  
For this study, the authors determined that two rounds would suffice, because the content was 
already conceived and the task required was straightforward: recommending to reject, exclude, or 
modify (with justification). In the present study, participants were not asked to create content, but 
only to agree on content. The amount of rounds is usually determined by the initial needs (Ludwig, 
1994); the more complex the needs, the higher the number of rounds required.  
 
e. Experts, users and professionals consulted 
To create a panel of experts: 
- A list of experts (in Mental Health, Suicide Prevention, AI and New Technologies, as 
well as AI users) was established (see results section) who were sent individual 
invitations (see results section) 
- Two Canadian academic research organizations were contacted that specializes in a. 
health care, b. health care and new technologies, and c. ethics and AI. Group invitations 
were sent through their mailing lists.  
 
f. Consultation process 
First step: An initial list of 47 items was established, divided into 5 categories: “Description of 
the Autonomous Intelligence System”, “Privacy and Transparency”, “Security”, “Health-Related 
Risks”, “Biases”. The consultation was conducted using the Lime Survey online software, hosted 
on the Université du Québec à Montréal’s servers (UQAM). The consent form was accessible on 
the first page of the survey, as a PDF in English. If the response to the consent form was negative, 
it was not possible to participate in the survey. The survey was anonymous, (Linstone & Turoff, 
2002), although participants were requested to provide an email address to be contacted for the 
second round, which would not be associated with their responses in order to maintain anonymity.  
The instructions for the first round were to: a. approve (explain the reason), b. exclude (explain 
the reason), or c. modify (explain the reason). The data collection phase lasted 60 days, from April 
15, 2018 to June 15, 2018.  
At the end of this first phase, the research team wrote a report with all the modifications completed, 
along with a detailed summary of the number of items excluded, modified, or kept as is. To be 
retained, an item had to have a score of 80% agreement or higher at the “kept as is” option (Jorm, 
2015). To be excluded, an article needed to have 50% of agreement or less as “kept as is” or 80% 
or more to “exclude the item”.  
Second step: an edited survey was sent to the participants who provided their email address (16 
participants). The summary and report were included in the invitation email. The second Delphi 
round requested the experts to revise the modifications and verify if the updates were satisfactory. 
Participants were then asked to either keep each item or exclude it. This step followed the 
recommendations of the COSMIN checklist (Mokkink et al., 2010).  
 
Results 
a. Panel 
32 experts were invited to participate by individualized emails. These participants were: a. 
professors, experts and researchers in suicide prevention and ICT (n=12), b. professors and 
researchers who have published on AI in Mental Health (n=10), c. researchers who have published 
on ethics and AI (n=3), d. researchers in psychology or psychiatry, experts in the use of ICT (n=2), 
e. experts in ethics and AI (n=2), f. professor of computer engineering specialized in AI (n=1), f. 
two entrepreneurs working on the use of AI in mental health and suicide Prevention (n=2).  
 
b. Response 
16 responses were collected in the first round. This is above the suggested minimum of 15 for a 
first round of a Delphi survey (Hasson et al., 2000). The participants were distributed as follows : 
5 were specialized in AI and mental health, 5 were specialized in technologies and mental health, 
6 were specialized in suicide prevention and new technologies. 
The two aforementioned Canadian research groups distributed a collective invitation to participate 
in their mailing lists. The group specialized in ICT, media studies and health has a mailing list of 
over 100 members. The group specialized in ethics and AI has a mailing list of 49 researchers 
across Canada.  
Individual invitations have a potential response rate of 40%. In the second round, the 16 
participants of the first round were invited, 8 participated. Which corresponded to a response rate 
of 50%.  
 
c. Final checklist 
The initial checklist included 44 items. After the first round of consultation, 12 items were retained 
as is or slightly modified, (condition: 80% or more of agreement at the “keep the item as is” 
option), 27 items were modified (condition: between 50% and 80% of agreement at the option 
“keep the item as is” or at the option “modify the item”), 6 items were excluded (less than 50% of 
agreement on “keep as is”, or more than 50% at the option “remove the item”). The second round 
consisted of a final review of modifications of the 27 items, conducted by 8 of the 16 original 
participants partook in the second round. The final checklist consisted of 40 items (see Table 1): 
- “Description of the Autonomous Intelligent System” (n=8) 
- “Privacy and Transparency” (n=8) 
- “Security” (n=6) 
- “Health-Related Risks” (n=8) 
- “Biases” (n=8) 
 
d. Relevance and target users of the checklist 
In the first round of the Delphi, the 16 participants were asked if they thought this instrument was 
relevant, using a Likert Scale ranging from 1 to 5 (1 being not relevant to 5 being very relevant). 
On average, the MHSP was considered relevant by the participants with an average of 4.06 out of 
5 (s=0.68).  
When asked who could use this checklist, participants could not categorically assert who could 
use it. They were mostly uncertain for researchers (56.25%), AI developers (81.25%) or mental 
health professionals (68.75%). The rejection rate (“No”) was two times 0% (for researchers and 
AI developers), and once 18.75% (for mental health professionals). This might indicate that the 
ethical considerations of the checklist might not be relevant to the day-to-day jobs of mental health 
professionals. The detailed results (see Table 2) indicate that this checklist is relevant, but might 
require in the future to be tailored depending on who could use this tool. 
 
Table 1 : Final questions 
Question Yes No  Uncertain 
Will researchers use this checklist ? 7 (43.75%) 0 (0%) 9 (56.25%) 
Will AI developers use this checklist ? 3 (18.75%) 0 (0%) 13 (81.25%) 
Will mental health professionals use this 
checklist? 2 (12.5%) 3 (18.75%) 11 (68.75%) 
 
Table 2 : The Canada Protocol – MHSP 
(see table file) 
 
Discussion 
In all the studies and reviews on AI and ethics, the research team identified only three ethical tools. 
None of them are specialized in mental health or suicide prevention. The first, “Geneth: A General 
Ethical Dilemma Analyzer” (Anderson & Anderson, 2014) is a general ethical dilemma analyzer 
using Machine Learning. The second ethics tool is called “DELICATE: A Checklist for Trusted 
Learning Analytics” (Drachsler & Greller, 2016). This checklist asks the user or reader two or 
three questions concerning 8 key actions: determination, explain, legitimate, involve, consent, 
anonymize, technical, external. The third tool is a simple specialized checklist, made available on 
Medium website, on the policy design process including some ethical challenges: “A Canadian 
Algorithmic Impact Assessment” (Karlin, 2018). These tools are not directly relevant for most 
professionals in mental health. The Geneth tool may also be too technically complex for most 
users. The DELICATE checklist could be applied to a large number of situations, but was initially 
intended to facilitate a trusted implementation of Learning Analytics. The initial intent of this tool 
might make it a bit off-target for this study’s requirements. For all these reasons, it seems that the 
Canada Protocol can serve two different current needs: 1. A tool promoting strong ethical 
principles when using AI or BD and providing insights on what are the ethical challenges in mental 
health and suicide prevention; how to identify and prevent them, 2. A tool that can be used and 
understood by most health care professionals and computer engineers. 
Some of the core principles of the Canada Protocol are similar to the ethical guidelines of Luxton 
for the use of Artificial Intelligence Care Providers (AICP)(Luxton, 2014). For example, the author 
made recommendations for the design of an AICP. Several address similar issues as the Canada 
Protocol, such as “ 2. Identify and provide specifications of use and limits of autonomy of AICP 
systems to end users” or “5. Provide built-in safeguards to assure that systems are only able to 
provide services within established boundaries of competence and domain of use”.  
 
Limitations 
Delphi consultations usually aim to gather expert opinions on a specific topic. This notion of expert 
opinions has long been discussed and debated. Some researchers consider it as a subjective 
perception (Linstone & Turoff, 2002). Therefore, it is acknowledged that this Delphi Consultation 
has taken into consideration some subjective opinions. 
One way to reinforce the validity of the tool could be to conduct another Delphi consultation on 
the applicability of the checklist. This could include a larger committee of experts, including more 
computer engineering and ethics specialists. 
Another limitation is that it was difficult to design a checklist that could be accessible and 
understood by the largest audience possible. By doing so, the authors had to make compromises. 
Some terms were considered too technical for some reviewers who identified as clinician or 
researchers in psychology. More common synonyms were used.  
 
Conclusion 
To date, the authors have not found validated ethical guidance tools on AI in mental health or 
suicide prevention. Considering the sudden rise of AI in society and in health care, they developed 
and proposed an ethical checklist to help identify potential ethical risks, biases, and challenges: 
the Canada Protocol - MHSP . Checklists are commonly used in health care and it was assumed 
that developing a familiar tool could increase its appeal and utility. In order to validate its content, 
this study used a two-round Delphi Consultation. The final checklist is composed of 38 items, 
divided into five categories: Description of the Autonomous Intelligent System” (n=8), “Privacy 
and Transparency” (n=8), “Security” (n=6), “Health-Related Risks” (n=8), “Biases” (n=8). 
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